Bourne Lent Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Hold |
|
|||||
|
2025
Q1 | $390K | Sell |
|
|||||
|
2024
Q4 | $331K | Hold |
|
|||||
|
2024
Q3 | $300K | Hold |
|
|||||
|
2024
Q2 | $246K | Hold |
|
|||||
|
2024
Q1 | $262K | Hold |
|
|||||
|
2023
Q4 | $290K | Sell |
|
|||||
|
2023
Q3 | $643K | Hold |
|
|||||
|
2023
Q2 | $661K | Hold |
|
|||||
|
2023
Q1 | $712K | Hold |
|
|||||
|
2022
Q4 | $737K | Buy |
|
|||||
|
2022
Q3 | $523K | Buy |
|
|||||
|
2022
Q2 | $518K | Hold |
|
|||||
|
2022
Q1 | $498K | Buy |
|
|||||
|
2021
Q4 | $594K | Hold |
|
|||||
|
2021
Q3 | $571K | Hold |
|
|||||
|
2021
Q2 | $563K | Buy |
|
|||||
|
2021
Q1 | $495K | Buy |
|
|||||
|
2020
Q4 | $434K | Hold |
|
|||||
|
2020
Q3 | $471K | Hold |
|
|||||
|
2020
Q2 | $574K | Hold |
|
|||||
|
2020
Q1 | $557K | Buy |
|
|||||
|
2019
Q4 | $354K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $213K | Hold |
|
|||||
|
2016
Q4 | $224K | Buy |
|
|||||
|
2016
Q3 | $228K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $202K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $234K | Buy |
|